The international trade in human vaccines before Covid‐19
Dados Bibliográficos
| ID | 21543422 |
|---|---|
| Autores | Agustí Segarra‐Blasco (0000-0001-6316-3171, Department of Economics and ECO‐SOS, Research Group of Industry and Territory Universitat Rovira i Virgili Reus Spain), Mercedes Teruel (0000-0002-4104-7679, Department of Economics and ECO‐SOS, Research Group of Industry and Territory Universitat Rovira i Virgili Reus Spain), Sebastiano Cattaruzzo (0000-0001-8857-8314, Department of Economics Università Ca' Foscari Venezia Venice Italy, autor correspondente) |
| Ano | 2024 |
| Volume | 47 |
| Fascículo | 5 |
| Páginas | 1978-2008 |
| Data de publicação | 2024-05-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | World Economy (JOURNAL) |
| Identificadores do periódico | ISSN: 0378-5920 • E-ISSN: 1467-9701 |
| Editora | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/twec.13533 |
| OpenAlex | W4388203046 |
| Idioma | EN |
| Referências citadas | 47 |
The recent COVID‐19 pandemic has highlighted the importance of global access to human vaccines. There is, however, no empirical work on either the unequal distribution of international trade or on its determinants. Applying a gravity model to the UN Comtrade database between 2000 and 2019, we explain the patterns of bilateral trade across 116 countries. Using the Poisson Pseudo‐Maximum Likelihood methodology, our results show that inequalities in international vaccine trade have steadily increased. In general, supply and demand drivers play a role in explaining the flow of human vaccines. The impact of these drivers varies depending on the income level of the importing country. High‐income countries intensify their flows with demand factors such as GDP per capita, or supply factors such as the location of big pharmaceutical companies. Conversely, low‐income countries receive more vaccines according to their population. Our results show that a poor country that houses a big pharmaceutical company acts as an exporting platform to developing and poor countries. Middle‐income countries present features similar to rich countries both by producing more and also by exporting more. The imbalance endangers the global fight against the current COVID‐19 pandemic
Business · Developing country · Development economics · Economic growth · Economics · Gravity model of trade · International economics · International trade · Pandemic · Per capita · Per capita income · Population · Global trade and economics · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy
An Advanced Guide to Trade Policy Analysis
Impact of Vaccines; Health, Economic and Social Perspectives
Links and Impacts
Economic integration agreements, border effects, and distance elasticities in the gravity equation
Once we have it, will we use it? A European survey on willingness to be vaccinated against Covid-19
Export Versus FDI with Heterogeneous Firms
Market Size in Innovation
The Impact of Trade on Intra-Industry Reallocations and Aggregate Industry Productivity
Gravity with Gravitas
How Covid‐19 vaccine supply chains emerged in the midst of a pandemic
Trade in health products and population health
Inter‐country distancing, globalisation and the coronavirus pandemic
The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken
The Log of Gravity
Enhancing the WHO’s Proposed Framework for Distributing Covid-19 Vaccines Among Countries
The evolution of the pharmaceutical industry
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |